Your browser doesn't support javascript.
loading
Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo.
An, Meirui; Raguram, Aditya; Du, Samuel W; Banskota, Samagya; Davis, Jessie R; Newby, Gregory A; Chen, Paul Z; Palczewski, Krzysztof; Liu, David R.
Affiliation
  • An M; Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Raguram A; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.
  • Du SW; Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USA.
  • Banskota S; Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Davis JR; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.
  • Newby GA; Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USA.
  • Chen PZ; Gavin Herbert Eye Institute, Center for Translational Vision Research, Department of Ophthalmology, University of California, Irvine, CA, USA.
  • Palczewski K; Department of Physiology and Biophysics, University of California, Irvine, CA, USA.
  • Liu DR; Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Nat Biotechnol ; 2024 Jan 08.
Article in En | MEDLINE | ID: mdl-38191664
ABSTRACT
Prime editing enables precise installation of genomic substitutions, insertions and deletions in living systems. Efficient in vitro and in vivo delivery of prime editing components, however, remains a challenge. Here we report prime editor engineered virus-like particles (PE-eVLPs) that deliver prime editor proteins, prime editing guide RNAs and nicking single guide RNAs as transient ribonucleoprotein complexes. We systematically engineered v3 and v3b PE-eVLPs with 65- to 170-fold higher editing efficiency in human cells compared to a PE-eVLP construct based on our previously reported base editor eVLP architecture. In two mouse models of genetic blindness, single injections of v3 PE-eVLPs resulted in therapeutically relevant levels of prime editing in the retina, protein expression restoration and partial visual function rescue. Optimized PE-eVLPs support transient in vivo delivery of prime editor ribonucleoproteins, enhancing the potential safety of prime editing by reducing off-target editing and obviating the possibility of oncogenic transgene integration.

Full text: 1 Database: MEDLINE Language: En Journal: Nat Biotechnol Journal subject: BIOTECNOLOGIA Year: 2024 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Language: En Journal: Nat Biotechnol Journal subject: BIOTECNOLOGIA Year: 2024 Type: Article Affiliation country: United States